{"id":4047,"date":"2025-03-14T06:38:15","date_gmt":"2025-03-14T06:38:15","guid":{"rendered":"http:\/\/legatobio.com\/?p=4047"},"modified":"2025-03-14T06:38:15","modified_gmt":"2025-03-14T06:38:15","slug":"legato-biologicss-sparxnano-technology-accelerating-nanobody-discovery","status":"publish","type":"post","link":"\/?p=4047","title":{"rendered":"Legato Biologics&#8217;s SparxNano\u2122 Technology: Accelerating Nanobody Discovery"},"content":{"rendered":"<figure class=\"wp-block-post-featured-image\"><img width=\"2560\" height=\"1194\" src=\"\/app\/uploads\/2025\/03\/image5-scaled.webp\" class=\"attachment-post-thumbnail size-post-thumbnail wp-post-image\" alt=\"\" decoding=\"async\" loading=\"lazy\" srcset=\"\/app\/uploads\/2025\/03\/image5-scaled.webp 2560w, \/app\/uploads\/2025\/03\/image5-300x140.webp 300w, \/app\/uploads\/2025\/03\/image5-1024x477.webp 1024w, \/app\/uploads\/2025\/03\/image5-768x358.webp 768w, \/app\/uploads\/2025\/03\/image5-1536x716.webp 1536w, \/app\/uploads\/2025\/03\/image5-2048x955.webp 2048w\" sizes=\"(max-width: 2560px) 100vw, 2560px\" \/><\/figure>\n\n\n<p>Legato Biologics\u2019 SparxNano\u2122 technology is a cutting-edge platform designed to rapidly identify high-affinity, highly selective nanobodies targeting specified extracellular proteins within just four months. This accelerated timeline allows for faster therapeutic development, providing a competitive edge in the biologics landscape. Leveraging advanced discovery techniques and proprietary processes, SparxNano\u2122 ensures precise target engagement and exceptional specificity, making it an ideal solution for challenging therapeutic targets.<\/p>\n<p>The platform harnesses the unique advantages of nanobody technology, such as their small size, high stability, and strong binding affinity, to address complex biological challenges. Unlike conventional monoclonal antibodies, nanobodies developed through SparxNano\u2122 exhibit superior tissue penetration and robust performance in diverse applications, including oncology, autoimmune diseases, and targeted drug delivery. The technology identifies and optimizes nanobody candidates with enhanced binding and physiochemical properties, meeting the rigorous demands of therapeutic and diagnostic applications.<\/p>\n<p>SparxNano\u2122 provides a seamless, end-to-end development process, from target selection and library screening to lead optimization and characterization. Our proprietary platform employs advanced screening strategies and bioinformatics-driven selection methods to identify the most promising candidates promptly and efficiently. With a focus on extracellular protein targets, SparxNano\u2122 offers a highly tailored approach, allowing partners to advance their therapeutic programs with confidence and speed.<\/p>\n<p>By integrating efficiency, precision, and innovation, SparxNano\u2122 empowers our partners to accelerate their biologics pipelines and achieve significant milestones in short timeframes. With a proven track record of delivering high-quality nanobody candidates, Legato Biologics stands as a trusted partner for companies seeking to harness the power of nanobody therapeutics for groundbreaking medical innovations.<\/p>\n\n\n","protected":false},"excerpt":{"rendered":"<p>SparxNano\u2122 technology is a cutting-edge platform designed to rapidly identify high-affinity, highly selective nanobodies targeting specified extracellular proteins within just four months.<\/p>\n","protected":false},"author":1,"featured_media":4022,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":[],"categories":[54],"tags":[],"_links":{"self":[{"href":"\/index.php?rest_route=\/wp\/v2\/posts\/4047"}],"collection":[{"href":"\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=4047"}],"version-history":[{"count":1,"href":"\/index.php?rest_route=\/wp\/v2\/posts\/4047\/revisions"}],"predecessor-version":[{"id":4048,"href":"\/index.php?rest_route=\/wp\/v2\/posts\/4047\/revisions\/4048"}],"wp:featuredmedia":[{"embeddable":true,"href":"\/index.php?rest_route=\/wp\/v2\/media\/4022"}],"wp:attachment":[{"href":"\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=4047"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=4047"},{"taxonomy":"post_tag","embeddable":true,"href":"\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=4047"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}